Top Markets
Coin of the day
Allied Biotech Corporation Allied Biotech Corporation

Allied Biotech Corporation

1780
Rank in Stocks #22532
Allied Biotech Corporation operates as a global producer and supplier... Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
Share Price
$0.7981556
Last synced: 2026-08-21
Market Cap
$87.06M
Change (1 day)
0.40%
Change (1 year)
38.97%
Country
TW
Trade Allied Biotech Corporation (1780)

Category

Revenue for Allied Biotech Corporation (1780)
Revenue in Aug 2026 TTM: 0
According to Allied Biotech Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Allied Biotech Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors